IHS Chemical Week

Regions :: North America :: U.S.

Merck to License Codexis Technology

1:59 PM MDT | August 6, 2007 | Chemical Week Editorial Staff

Codexis (Redwood City, CA) says it has entered into an agreement with Merck, under which Merck will gain non-exclusive access to Codexis’s biocatalysts for in-house screening. Financial details were not disclosed. Codexis says it has developed sets of diagnostic enzymes optimized for pharmaceutical manufacturing that partners can use internally to screen for reactivity in desired process...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa